Pages that link to "Q43727815"
Jump to navigation
Jump to search
The following pages link to Chronic graft-versus-host disease after allogeneic blood stem cell transplantation (Q43727815):
Displaying 50 items.
- Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept (Q33213561) (← links)
- Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study (Q33347659) (← links)
- Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies. (Q33348605) (← links)
- Transplantation outcome in allogeneic PBSCT patients according to a new chronic GVHD grading system, including extensive skin involvement, thrombocytopenia, and progressive-type onset (Q33360712) (← links)
- Clinical significance of platelet count at day +60 after allogeneic peripheral blood stem cell transplantation (Q33370269) (← links)
- Thrombocytopenia and hemostatic disorders in chronic graft versus host disease (Q33385836) (← links)
- Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study (Q33397272) (← links)
- Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children (Q33423714) (← links)
- Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease (Q33809599) (← links)
- Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation (Q33839876) (← links)
- Eosinophils in the blood of hematopoietic stem cell transplanted patients are activated and have different molecular marker profiles in acute and chronic graft-versus-host disease (Q34442851) (← links)
- Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031. (Q34679045) (← links)
- Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation (Q35054413) (← links)
- Biomarkers in chronic graft-versus-host disease (Q35094374) (← links)
- Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes (Q35142616) (← links)
- Activation and Expansion of CD8+ T Effector Cells in Patients with Chronic Graft-versus-Host Disease (Q35224975) (← links)
- Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031. (Q35300908) (← links)
- Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomes (Q35554269) (← links)
- Are predictive factors clinically useful in bone marrow transplantation? (Q35561009) (← links)
- Chronic graft-versus-host disease: where do we go from here? (Q35638378) (← links)
- CD34 cell dose and chronic graft-versus-host disease after human leukocyte antigen-matched sibling hematopoietic stem cell transplantation (Q35733259) (← links)
- Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation (Q35750957) (← links)
- Chronic graft versus host disease (Q35772587) (← links)
- Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation (Q35848407) (← links)
- Risk Factors, Pattern and Clinical Outcome of Acute Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplant (Q35975019) (← links)
- CD34 + cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation. (Q35994928) (← links)
- Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants (Q36002331) (← links)
- Overview of T-cell depletion in haploidentical stem cell transplantation (Q36159937) (← links)
- Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. (Q36491894) (← links)
- National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis. (Q36747224) (← links)
- Oral graft-versus-host disease. (Q36932886) (← links)
- Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes (Q36996205) (← links)
- Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms (Q37205584) (← links)
- Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells (Q37223366) (← links)
- Bilateral corneal ulceration in ocular graft-versus-host disease (Q37278726) (← links)
- Regression of eosinophil counts after diagnosis of chronic graft-versus-host disease as a potential marker for improved clinical outcome (Q37560732) (← links)
- The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant (Q37689179) (← links)
- Graft-vs-host disease following allogeneic hematopoietic cell transplantation (Q37942818) (← links)
- Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children (Q38129306) (← links)
- Concise review: the bone marrow niche as a target of graft versus host disease (Q38192559) (← links)
- Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice (Q38774962) (← links)
- Female donors and donors who are lighter than their recipient are less likely to meet the CD34+ cell dose requested for peripheral blood stem cell transplantation. (Q39186228) (← links)
- Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation. (Q39533852) (← links)
- Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia (Q39748070) (← links)
- Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria. (Q39763917) (← links)
- Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants (Q40721706) (← links)
- BK virus-hemorrhagic cystitis following allogeneic stem cell transplantation: Clinical characteristics and utility of leflunomide treatment (Q40791452) (← links)
- Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma. (Q41509697) (← links)
- Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma (Q43732453) (← links)
- Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies (Q43864374) (← links)